Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | PREP | P48147 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 5/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CTSB | P07858 | 3/20 | 0.38 |
| ▸ | CTSS | P25774 | 2/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1841848 | 0.88 | CASP3 (0.44) | CASP3PREPCTSKCASP1CTSB | |
| SCHEMBL12156504 | 0.88 | CASP3 (0.44) | CASP3PREPCTSKCASP1CTSB | |
| SCHEMBL2786342 | 0.88 | CASP3 (0.44) | CASP3PREPCTSKCASP1CTSB | |
| SCHEMBL12156505 | 0.86 | CASP3 (0.42) | CASP3PREPMEN1KMT2AGPR55 | |
| SCHEMBL13600773 | 0.86 | CASP3 (0.42) | CASP3PREPMEN1KMT2AGPR55 | |
| SCHEMBL3744158 | 0.85 | CASP3 (0.45) | CASP3PREPCTSKCASP1CTSB | |
| SCHEMBL1842398 | 0.84 | CASP3 (0.41) | CASP3PREPMEN1KMT2AGPR55 | |
| SCHEMBL12156507 | 0.84 | PREP (0.40) | CASP3PREPCTSKCASP1CTSB | |
| SCHEMBL13411399 | 0.84 | CASP3 (0.41) | CASP3PREPMEN1KMT2AGPR55 | |
| SCHEMBL13600774 | 0.84 | PREP (0.40) | CASP3PREPCTSKCASP1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194051-B1 | Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity | BRISTOL MYERS SQUIBB CO (US) | 2011-08-31 | — | — | EP | claimed |